Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.

Publication

Citation
Edmondson SD, Zhu C, Kar NF, Di Salvo J, Nagabukuro H, Sacre-Salem B, Dingley K, Berger R, Goble SD, Morriello G, Harper B, Moyes CR, Shen DM, Wang L, Ball R, Fitzmaurice A, Frenkl T, Gichuru LN, Ha S, Hurley AL, Jochnowitz N, Levorse D, Mistry S, Miller RR, Ormes J, Salituro GM, Sanfiz A, Stevenson AS, Villa K, Zamlynny B, Green S, Struthers M, Weber AE.: Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder. J Med Chem, Volume 59 (2), 2016
Authors
Ball R, Berger R, Di Salvo J, Dingley K, Edmondson SD, Fitzmaurice A, Frenkl T, Gichuru LN, Goble SD, Green S, Ha S, Harper B, Hurley AL, Jochnowitz N, Kar NF, Levorse D, Miller RR, Mistry S, Morriello G, Moyes CR, Nagabukuro H, Ormes J, Sacre-Salem B, Salituro GM, Sanfiz A, Shen DM, Stevenson AS, Struthers M, Villa K, Wang L, Weber AE., Zamlynny B, Zhu C
Journal
J Med Chem
Year
2016
PubMed
26709102
Machine-readable
REST APIRDF
Palacky University Olomouc

Palacky University Olomouc

Faculty of Science

Department of Physical Chemistry

tř. 17. listopadu 1192/12

771 46 Olomouc

Czech Republic

How to cite?

Juračka J., Šrejber M., Melíková M., Bazgier V., Berka K.: MolMeDB: Molecules on Membranes Database. Database, Volume 2019, 2019, baz078, https://doi.org/10.1093/database/baz078

Follow us

FacebookGithub

Financial Support

  • MolMeDB interoperability with UniProt and SwissLipids – MEYS Czech-Swiss project ELIXIR-IMPACT 8K0208 (2026–2028)
ELIXIRGAČRUP Olomouc